Hetzer Medical Indonesia Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Venteny Fortuna International Tbk. trades at Rp61 (market cap 394.71B, 64M 24h volume). The key difference: Venteny Fortuna International Tbk. is far larger — about 3.1× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 64M). Which is the better fit depends on your goals.
| MEDS | VTNY | |
|---|---|---|
Market Cap | 126.56B | 394.71B |
Volume | 319.74M | 64M |
Lot | 3.2M | 639.98K |
Turnover | 27.4B | 4.15B |
Average Price | 85.68 | 64.9 |
Value | 27.4B | 4.15B |
Indicative Equilibrium Price | 82 | 61 |
Indicative Equilibrium Volume | 12.79K | 1.95K |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →